Trial Profile
Vigabatrin for Treatment of Methamphetamine Dependence: A Phase II Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Vigabatrin (Primary)
- Indications Drug dependence
- Focus Therapeutic Use
- Sponsors Catalyst Pharmaceuticals
- 14 Oct 2014 New trial record